PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Alexa Fluor® 488 anti-Giantin, 100 μl
Alexa Fluor® 488 anti-HA.11 Epitope Tag, 100 μl
Alexa Fluor® 488 anti-human/rat CD51 (Integrin αvβ5), 100 tests
Alexa Fluor® 488 anti-human/rat CD51 (Integrin αvβ5), 25 tests
Alexa Fluor® 488 anti-Tubulin β 3 (TUBB3), 100 μl
Alexa Fluor® 488 anti-β-Amyloid, 1-16, 200 μl
Alexa Fluor® 594 anti-HA.11 Epitope Tag, 100 μl
Alexa Fluor® 594 anti-NUP153, 100 μg
Alexa Fluor® 594 anti-O-GlcNAc, 100 μg
Alexa Fluor® 594 anti-Tubulin β 3 (TUBB3), 100 μg
Alexa Fluor® 594 anti-Tubulin β 3 (TUBB3), 25 μg
Alexa Fluor® 647 anti-human/rat CD51 (Integrin αvβ5), 100 tests
Alexa Fluor® 647 anti-human/rat CD51 (Integrin αvβ5), 25 tests
Alexa Fluor® 647 anti-Tubulin β 3 (TUBB3), 100 μg
Alexa Fluor® 647 anti-Tubulin β 3 (TUBB3), 25 μg
Anti-6-His Epitope Tag Affinity Matrix, 1 ml